Alice A. Tomei, Ph.D., is Assistant Professor in the department of Biomedical Engineering at the University of Miami and director of the Islet Immunoengineering Laboratory at the Diabetes Research Institute. Dr. Tomei has a background in both material and biological engineering.
She comes to the DRI from École Polytechnique Fédérale (EPFL), Lausanne, Switzerland, Institute of Bioengineering, where she worked under the direction of Professor Jeffrey A. Hubbell, a world-renowned leader in biomaterials science. The translation of her research into a therapeutic application has resulted in two patent applications.
At the DRI, the primary focus of Dr. Tomei’s research is in engineering immunoprotection of islet transplants via islet immunoisolation and local immunomodulation. Specifically, she is developing platforms and technologies for improving cell encapsulation through novel conformal coating. Her strategies are focused on mitigating rejection and the recurrence of autoimmunity in patients with type 1 diabetes. She is also investigating and engineering methods to locally manipulate the immunological balance to establish tolerance. These strategies are focused on mitigating both allo and xeno-rejection and the recurrence of autoimmunity in patients with type 1 diabetes mellitus.
Dr. Tomei’s research findings have been published in some of the most prestigious peer-reviewed scientific journals.
Read Dr. Tomei's full biosketch>
Read more at: www.TomeiLab.com>